论文部分内容阅读
[目的]观察三芪液联合尼莫地平治疗气虚血瘀型脑中风后遗症疗效。[方法]使用随机平行对照方法,将60例住院及门诊患者按病志号抽签/就诊顺序号方法简单随机分两组,均抗凝、扩血管。对照组30例尼莫地平,40mg/次,3次/d。治疗组30例三芪液(黄芪18g,三七6g,芒果叶12g),1剂/d,水煎600m L,早晚口服;尼莫地平治疗同对照组。连续治疗12周为1疗程。观测临床症状、神经功能缺损评分、不良反应。治疗1疗程,判定疗效。[结果]临床疗效、神经功能疗效治疗组优于对照组(P<0.05)。神经功能缺损评分两组均有改善(P<0.05,P<0.01),治疗组改善优于对照组(P<0.01)。[结论]三芪液联合尼莫地平治疗气虚血瘀型脑中风后遗症,疗效满意,无严重不良反应,值得推广。
[Objective] To observe the curative effect of Sanqi liquid combined with nimodipine on stroke sequelae of qi deficiency and blood stasis type. [Methods] Using randomized parallel control method, 60 cases of inpatients and outpatients were randomly divided into two groups randomly according to the number of patient’s lottery / visiting sequence number, both anticoagulant and vasodilator. Control group 30 cases of nimodipine, 40mg / time, 3 times / d. Treatment group, 30 cases of Sanqi liquid (Astragalus 18g, 376g, mango leaves 12g), 1 / d, decoction 600m L, sooner or later oral; nimodipine treatment with the control group. Continuous treatment for 12 weeks for a course of treatment. Observation of clinical symptoms, neurological deficit score, adverse reactions. Treatment of a course of treatment to determine the efficacy. [Results] The clinical curative effect and neurological curative effect were better than the control group (P <0.05). Neurological deficit scores were improved in both groups (P <0.05, P <0.01), and improvement in the treatment group was better than that in the control group (P <0.01). [Conclusion] Sanqi liquid combined with nimodipine in treatment of sequelae of cerebral apoplexy with deficiency of qi and blood stasis has satisfactory curative effect and no serious adverse reactions, which deserves promotion.